Xtant Medical Holdings Inc (NYSE American:XTNT)

6.15
Delayed Data
As of May 25
 +0.13 / +2.16%
Today’s Change
3.96
Today|||52-Week Range
14.52
-10.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues21.4M19.8M19.3M17.9M
 
 
 
 
 
Cost of Goods Sold7.2M6.5M9.0M5.1M
 
 
 
 
 
Depreciation And Amortization2.1M3.2M1.4M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income12.1M10.0M8.9M11.2M
 
 
 
 
 
General Expenses16.4M12.7M13.3M12.2M
 
 
 
 
 
Research And Development640.0K504.2K598.0K414.0K
 
 
 
 
 
Total Operating Expenses25.7M22.5M23.7M18.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-2.7M-4.4M-924.0K
 
 
 
 
 
Extraordinary Credit0.000.0066.0K0.00
 
 
Extraordinary Charge-394.3K-811.1K-19.9M-771.0K
 
 
 
 
 
Interest Expense On Debt3.3M3.8M4.2M3.5M
 
 
 
 
 
Other Expenses-1.6M-1.2M-11.0K-13.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.7M-8.5M-28.4M-5.3M
 
 
 
 
 
Net Income-9.7M-8.5M-28.4M-5.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M1.5M1.5M7.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M1.5M1.5M7.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.48-$5.64-$18.76-$0.70
 
 
 
 
 
EPS Diluted-$6.48-$5.64-$18.77-$0.70